Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Vimta Labs

Sector: Healthcare | Industry: Drugs & Pharma
R 104.50 -1.75  | -1.65% -58.79% 11.81 236.44
NSE Price: Oct 22, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 22, 15:59 104.50 -1.75 -1.65% 104.05 106.25 24,272 103.05 - 107.85
BSE Oct 22, 2019 106.95 1.25 1.18% 111.95 105.70 462 103.40 - 111.95
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 24,447 P/B: 1.37 NSE Code: VIMTALABS
52-Week Range: R 88.10 - 333.00 Dividend Yield: 1.87% BSE Code: 524394
TTM EPS: R 9.06 Book Value: R 78.13 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Vimta Labs -65.97 2.15 -25.29 -57.73 2.19 2.98 12.07
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 15.91 19.47 10.82
Net Profit 54.03 57.86 13.84
EPS 54.03 57.86 13.84
Book Value 12.82 10.80 7.34
Average
Operating Margin 27.97 23.89 20.97
Net Margin 11.80 9.18 7.47
Return on Networth 15.64 11.71 8.90
Return on Investment 20.42 16.06 12.19
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -17.80 -19.25 -17.80
Operating Profit -47.24 -50.27 -47.24
Net Profit -82.71 -81.89 -82.71
EPS -82.71 -81.88 -82.71
TTM
Revenue -4.94 2.45 -4.94
Operating Profit -12.61 -5.68 -12.61
Net Profit -20.90 -8.27 -20.90
EPS -20.90 -8.27 -20.90
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Vimta Labs 236.44 202.14 20.02 9.84 15.64 1.37 11.81
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jul 31, 2015 LCGC Chromatography Solp Ltd  Buy Market 43,469 87.95 38.23
Mar 19, 2015 Rajeshwari Vungal  Buy Gift 41,418 84.80 35.12
Mar 12, 2015 Eurofins Analytical Services India Pvt Ltd  Buy Market 24,460 60.15 14.71
Feb 25, 2014 Eurofins Analytical Services India Pvt. Ltd.  Buy Market 28,964 56.15 16.26
Nov 19, 2013 Eurofins Analytical Services India Pvt. Ltd.  Buy Market 89,844 46.70 41.96
Fund Houses invested in the stock
Fund Jun-13 Mar-13 Dec-12 Sep-12 Jun-12
Nippon India Mutual Fund 1.403 1.403 1.403 1.448 -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Vimta Labs Ltd.

Address: Plot Nos 141/2 & 142, I D A Phase I I, Cherlapally, R R District, Hyderabad, Telangana - 500051 | Phone: 040- 27264141 | Fax: 040- 27263657

Email: [email protected]

Website: www.vimta.com

Registrar & Transfer Agent: Cil Securities Ltd

Address: 214 Raghava Ratna Towers , Chirag Ali Lane,Abidas,Hyderabad, 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas | Phone: 040-3203155/149 | Fax: 040-3203028

Essential checks
Altman Z-Score
4.68
Piotroski F-Score
9
Modified C-Score
1
5-Years Price to Earnings
11.81
5-Years Price to Book
1.37
Earnings Yield
EBIT / Enterprise value
12.28%
PEG
Price / Earnings to growth ratio
0.98
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59